BridgeMD
Prevention study for Depressive Symptoms
Official title Depression and Suicide Prevention in Adolescents Attending Special Schools
ClinicalTrials.gov ID: NCT06203899
What this study is testing
- What it's testing
- Depression is a major public health concern. In Dutch adolescents, the prevalence of major depressive disorder is estimated at 3.8%, and one in five adolescents report depressive symptoms.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 18
You may be able to join if
- Adolescents are in their second or third year of secondary education, ór adolescents will reach the age 14 or 15 in this academic year.
- Score above cut-off on depression symptom questionnaire (≥ 14 on the CDI-2; Bodden et al. (2016)).
You likely can't join if
- Adolescents who score 2 on item 8 of the CDI-2 or ≥ 23 on the VOZZ-screen (Kerkhof et al., 2015).
- Clinical depression based on the clinical interview at baseline ADIS-C (Silverman \& Albano, 1996).
- Absence of parental permission.
- Adolescent already receiving treatment for depressive symptomatology.
- Insufficient knowledge of the Dutch language.
The study team makes the final eligibility decision.
Where it's taking place
- Boekel, Noordoost Brabant, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boekel, Noordoost Brabant, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.